← Back to Search

RBT-1 for Cardiac Surgery Complications

N/A
Recruiting
Research Sponsored by Renibus Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects must have completed the REN-007 study to be eligible to participate in the Extension Study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post-cardiac surgery
Awards & highlights

Study Summary

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: Patient reported outcomes (PRO), using the EQ-5D questionnaire Clinical outcomes

Eligible Conditions
  • Cardiac Surgery Complications

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post-cardiac surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post-cardiac surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation

Trial Design

2Treatment groups
Experimental Treatment
Group I: RBT-1Experimental Treatment1 Intervention
Patients undergoing CABG, valve, or combined CABG/valve surgery
Group II: PlaceboExperimental Treatment1 Intervention
Patients undergoing CABG, valve, or combined CABG/valve surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
RBT-1
2019
Completed Phase 1
~60

Find a Location

Who is running the clinical trial?

Renibus Therapeutics, Inc.Lead Sponsor
7 Previous Clinical Trials
708 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
An Evaluation of Patient Reported Outcomes and Clinical Outcomes
2023. "An Evaluation of Patient Reported Outcomes and Clinical Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06092970.
All > Indianapolis
~267 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top